Recent Posts

• Seed Healthcare Leads Strategic Investment in Diadem
• Diadem Unveils Novel Findings on Early Alzheimer’s Disease Detection Using p53-Specific Antibody at CTAD 2024
• Diadem Appoints Michael Rasche as Chief Executive Officer
• Diadem SpA Announces Exclusive U.S. Licensing Agreement with Quest Diagnostics for Its AlzoSure® Predict Alzheimer’s Disease Prognostic Technology
• Understanding treatment pathways for Alzheimer’s Disease

Recent Comments